These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 1107249

  • 1. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
    Bubeník J.
    Int Urol Nephrol; 1975; 7(4):297-302. PubMed ID: 1107249
    [Abstract] [Full Text] [Related]

  • 2. In vitro cytotoxicity studies in bladder and renal cell cancer.
    Elhilali MM, Nayak SK.
    Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
    [Abstract] [Full Text] [Related]

  • 3. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.
    Perlmann P, Troye M, Pape G, Blomgren H, Johansson B.
    Urol Res; 1978 May; 6(4):207-9. PubMed ID: 741533
    [Abstract] [Full Text] [Related]

  • 4. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
    Hakala TR, Lange PH, Castro AE, Elliott AY, Fraley EE.
    J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity.
    Lee VK, Harriott TG, Kuchroo VK, Halliday WJ, Hellström I, Hellström KE.
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6286-90. PubMed ID: 3875859
    [Abstract] [Full Text] [Related]

  • 6. Human urinary bladder carcinoma cell line (T24): immunological studies and search for oncornavirus in T24 cell population and derived clones.
    Bubeník J, Asfahani A, Sherif M, El Ridi R, Mach O, Machácková M, Jandlová T, Símová J, Hanus M, Hradec E, Malkovský M.
    Neoplasma; 1978 Sep; 25(5):513-22. PubMed ID: 84343
    [Abstract] [Full Text] [Related]

  • 7. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M.
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract] [Full Text] [Related]

  • 8. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.
    Hakala TR, Lange PH, Castro A, Elliott A, Fraley EE.
    Cancer; 1974 Dec; 34(6):1929-34. PubMed ID: 4434325
    [No Abstract] [Full Text] [Related]

  • 9. Antigen(s) on human transitional cell carcinoma detected by a xenogeneic antiserum.
    Bloom ET.
    Urol Res; 1977 Dec; 5(3):141-8. PubMed ID: 919114
    [Abstract] [Full Text] [Related]

  • 10. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET, Ossorio RC, Brosman SA.
    Int J Cancer; 1974 Sep 15; 14(3):326-34. PubMed ID: 4477556
    [No Abstract] [Full Text] [Related]

  • 11. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ, Oldham RK, Djeu JY, Herberman RB, Cannon GB.
    Surg Forum; 1975 Sep 15; 26():122-4. PubMed ID: 56048
    [No Abstract] [Full Text] [Related]

  • 12. Transitional cell carcinoma of the bladder. Differences between primary tumour and following relapses.
    Pizza G, Viza D, Fini M, Cuzzocrea D, Menniti D, Corrado F.
    Eur Urol; 1980 Sep 15; 6(1):45-7. PubMed ID: 7353578
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay.
    Troye M, Perlmann P, Larsson A, Blomgren H, Johansson B.
    Int J Cancer; 1977 Aug 15; 20(2):188-98. PubMed ID: 892930
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A follow-up study of urinary bladder patients tested for tumour-related lymphocyte-mediated cytotoxicity.
    Larsson A, Näslund I, Troye M.
    Cancer Immunol Immunother; 1982 Aug 15; 14(2):82-5. PubMed ID: 6965230
    [Abstract] [Full Text] [Related]

  • 18. Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinoma.
    Bubeník J, Kieler J, Tromholt V, Hermann G, Jandlová T.
    Immunol Lett; 1988 Jun 15; 18(2):115-8. PubMed ID: 3261274
    [Abstract] [Full Text] [Related]

  • 19. A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma.
    O'Toole C.
    Int J Cancer; 1977 Mar 15; 19(3):324-31. PubMed ID: 844912
    [Abstract] [Full Text] [Related]

  • 20. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?
    O'Toole C, Perlmann P, Wigzell H, Unsgaard B, Zetterlund CG.
    Lancet; 1973 May 19; 1(7812):1085-8. PubMed ID: 4123535
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.